Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BIO Taps Big Pharma Execs for Federal Comparative Effectiveness Research Board Nominations

This article was originally published in The Pink Sheet Daily

Executive Summary

Four of BIO's six nominations are also PhRMA's nominations for the Patient-Centered Outcomes Research Institute board of governors.

You may also be interested in...



Pfizer's Lewis-Hall To Represent Pharma Interests On PCORI Board

Freda Lewis-Hall was among nominations from both BIO and PhRMA to sit on governing board of new comparative effectiveness entity created under the health care reform law.

Pfizer's Lewis-Hall To Represent Pharma Interests On PCORI Board

Freda Lewis-Hall was among nominations from both BIO and PhRMA to sit on governing board of new comparative effectiveness entity created under the health care reform law.

PCORI Should Take Lead On Public CER Inventory, Pharma Groups Tell HHS

Development of a publicly available repository of comparative effectiveness research should grow out of the work of the soon-to-be established Patient Centered Outcomes Research Institute, groups representing pharmaceutical industry interests urged in recent comments to HHS

Related Content

Topics

UsernamePublicRestriction

Register

OM014142

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel